The definitive treatment is surgery. At present, there is no role for chemotherapy or radiation for localized tumors as surgery alone is curative. However, for rare malignant presentation or transformation, currently, the evidence is lacking regarding optimal systemic chemotherapeutic regimens. These patients are treated in the lines of pancreatic adenocarcinoma (chemotherapy) or based on actionable mutations detected on next-generation sequencing.